Fairview Capital Partners

Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

Covr Financial Technologies, Inc. is a digitally enabled brokerage general agency based in Boise, Idaho, founded in 2013. The company specializes in providing life, long-term care, and disability insurance solutions tailored for financial institutions, advisors, and their clients. Covr offers a suite of digital platforms, including Covr Advisor, which helps financial advisors meet their clients' insurance needs by selecting appropriate products; Covr Consumer, which allows banks and credit unions to sell life insurance directly to customers; and Covr Insights, a tool for managing and analyzing existing life insurance policies. The company serves over 24,000 financial advisors and 13 million customers across 30 financial institutions, facilitating a simplified and efficient sales process for life insurance products.

Inbox Health Corp. is a digital healthcare company based in New Haven, Connecticut, founded in 2014. It specializes in developing a patient communication platform aimed at medical billers in the United States. The Inbox Health platform automates the patient communication process through bi-directional correspondence and utilizes proprietary algorithms, machine learning, and artificial intelligence. This enables patients to better understand their medical bills and access various payment options. By analyzing a wide range of data points across its customer base, the platform allows billers to personalize the billing, payment, and communication experiences for each patient, ultimately enhancing patient collections and overall satisfaction. The company's mission is to reduce administrative waste in healthcare by streamlining the billing and payment experience for patients.

SolarWinds Corporation is a provider of information technology infrastructure management software, catering to both domestic and international markets. The company focuses on developing products that assist IT professionals, managed service providers, and DevOps teams in monitoring and managing their IT environments, whether they are on-premises, in the cloud, or in hybrid settings. Its offerings include network management software that provides real-time visibility into network utilization and performance, as well as application performance management tools that enable monitoring of log data, cloud metrics, and applications. SolarWinds also delivers IT service management solutions to support outsourcing of IT services and offers remote monitoring software for desktops, laptops, and servers across various platforms. Additionally, the company provides an email protection and archiving platform to safeguard against cyber threats. Founded in 1999 and headquartered in Austin, Texas, SolarWinds aims to simplify IT management challenges with purpose-built, value-driven products and tools.

Covr Financial Technologies, Inc. is a digitally enabled brokerage general agency based in Boise, Idaho, founded in 2013. The company specializes in providing life, long-term care, and disability insurance solutions tailored for financial institutions, advisors, and their clients. Covr offers a suite of digital platforms, including Covr Advisor, which helps financial advisors meet their clients' insurance needs by selecting appropriate products; Covr Consumer, which allows banks and credit unions to sell life insurance directly to customers; and Covr Insights, a tool for managing and analyzing existing life insurance policies. The company serves over 24,000 financial advisors and 13 million customers across 30 financial institutions, facilitating a simplified and efficient sales process for life insurance products.

Rallybio, LLC is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, focused on developing innovative therapies for patients with severe and rare disorders. Founded in 2018, Rallybio is dedicated to addressing critical medical needs, particularly in the fields of hematology, immuno-inflammation, maternal-fetal health, and metabolic disorders. Its lead product candidate, RLYB211, is designed for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT), a serious condition that can lead to uncontrolled bleeding in fetuses and newborns. The company emphasizes the use of antibodies, small molecules, and engineered proteins in its drug development efforts. Rallybio is supported by a team of experienced professionals with extensive expertise in biopharmaceutical research and development, particularly in the realm of rare diseases.

Fluorous Technologies, Inc. is a chemical technology company specializing in the development and commercialization of fluorous products tailored for the life science market. Founded in 2000 and based in Ambridge, Pennsylvania, the company focuses on the creation of solid-phase extraction (SPE) cartridges, high-performance liquid chromatography (HPLC) columns, and various sorbent materials. Its product offerings include Rf8 homologs of various chemical compounds and biomolecule tags and reagents that aid in the synthesis, separation, and immobilization of chemical entities from both synthetic and natural mixtures. Fluorous Technologies employs patented technology to address challenges across the drug discovery and development process, providing solutions through service contracts, licenses, and collaborations. The company's innovative platform supports applications in small molecule and biomolecule synthesis, as well as broader life science applications, leveraging the unique properties of fluorous tags for enhanced molecular manipulation. Fluorous Technologies operates as a subsidiary of Boron Specialties LLC.